ALK-Abelló
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
ALK | CO
Overview
Corporate Details
- ISIN(s):
- DK0061802139
- LEI:
- 529900SGCREUZCZ7P020
- Country:
- Denmark
- Address:
- Bøge Alle 6-8, 2970 Hørsholm
- Website:
- https://www.alk.net
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ALK-Abelló is a global pharmaceutical company specializing in the research, development, and manufacturing of allergy immunotherapy (AIT) products. A pioneer in the field for over a century, the company focuses on creating treatments that address the underlying cause of allergies, rather than merely managing symptoms. Its portfolio encompasses a range of evidence-based AIT products, including tablets, drops, and injections, as well as emergency treatments for severe allergic reactions like anaphylaxis. ALK's primary therapeutic areas are respiratory allergies, food allergies, and anaphylaxis. The company is committed to scientific innovation and expanding access to its solutions, such as needle-free adrenaline treatments, to improve the lives of people with allergies worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 09:44 |
M&A Activity
|
Danish | 174.5 KB | ||
| 2025-09-17 09:44 |
M&A Activity
|
Danish | 10.0 KB | ||
| 2025-09-17 09:44 |
M&A Activity
|
English | 8.9 KB | ||
| 2025-09-17 09:44 |
M&A Activity
|
English | 274.6 KB | ||
| 2025-08-21 07:30 |
Earnings Release
|
English | 11.5 KB | ||
| 2025-08-21 07:30 |
Interim Report
|
English | 505.8 KB | ||
| 2025-08-21 07:30 |
Interim Report
|
English | 505.8 KB | ||
| 2025-08-21 07:30 |
Earnings Release
|
English | 12.0 KB | ||
| 2025-08-12 14:45 |
Earnings Release
|
Danish | 103.0 KB | ||
| 2025-08-12 14:45 |
Earnings Release
|
Danish | 3.7 KB | ||
| 2025-08-12 14:45 |
Earnings Release
|
English | 108.6 KB | ||
| 2025-08-12 14:45 |
Earnings Release
|
English | 3.2 KB | ||
| 2025-07-18 14:01 |
Regulatory News Service
|
Danish | 174.9 KB | ||
| 2025-07-18 14:01 |
Legal Proceedings Report
|
English | 5.2 KB | ||
| 2025-07-18 14:01 |
Regulatory News Service
|
Danish | 5.3 KB |
Automate Your Workflow. Get a real-time feed of all ALK-Abelló filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ALK-Abelló via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
